Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ICAD Inc ICAD

Healthcare Medical Devices
iCAD, Inc. provides artificial intelligence-powered cancer detection. Its ProFound Breast Health Suite enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Cancer Detection segment solutions include advanced artificial intelligence and image analysis workflow solutions that enable healthcare professionals to better serve patients by... see more

Recent & Breaking News (NDAQ:ICAD)

iCAD to Host First Quarter 2016 Financial Results Conference Call on Tuesday, May 3, 2016

GlobeNewswire April 21, 2016

iCAD Announces Computer Aided Detection Solution for Fujifilm's Aspire Cristalle Full Field Digital Mammography

Business Wire April 11, 2016

iCAD to Present at the 28th Annual ROTH Conference

GlobeNewswire March 9, 2016

iCAD Showcases Latest Technology Supporting Use of Xoft System for Non-melanoma Skin Cancer Treatment at AAD 2016

PR Newswire March 4, 2016

iCAD Announces Breakthrough Technology For Use With Digital Breast Tomosynthesis Exams At The European Congress Of Radiology

PR Newswire March 2, 2016

iCAD Reports Fourth Quarter and Full Year 2015 Financial Results

GlobeNewswire March 1, 2016

iCAD to Host Fourth Quarter and Full Year 2015 Financial Results Conference Call on Tuesday, March 1, 2016

GlobeNewswire February 2, 2016

iCad Completes Acquisition Of VuCOMP's Cancer Detection Portfolio

PR Newswire January 13, 2016

iCAD Expands Use of the Xoft Electronic Brachytherapy System in Europe, Asia and Australia

PR Newswire December 16, 2015

iCAD Appoints Andrew Sassine to Board of Directors

GlobeNewswire December 9, 2015

Researchers to Present Updated Data Regarding Intraoperative Radiation Therapy with the Xoft System at San Antonio Breast Cancer Symposium

PR Newswire December 8, 2015

Capturing Changes in Investor Sentiments - Research on TransAtlantic Petroleum, InfuSystem Holdings, iCAD, and Stellar Biotechnologies

Accesswire December 4, 2015

iCAD Featuring New Technology for Automated Breast Density Assessment and Showcasing Solutions for Tomosynthesis at RSNA 2015

PR Newswire November 30, 2015

iCAD To Present At The LD Micro "Main Event" Microcap Conference

Accesswire November 23, 2015

iCAD To Present At The LD Micro "Main Event" Microcap Conference

Accesswire November 23, 2015

iCAD Reports Use Of Xoft® Axxent® Electronic Brachytherapy System In The Treatment Of More Than 15,000 Non-Melanoma Skin Cancer Lesions

PR Newswire November 23, 2015

iCAD's Xoft System Selected as a Popular Science Magazine "Best of What's New" Award Winner for 2015

PR Newswire November 18, 2015

iCAD to Present at the Drexel Hamilton Micro Cap Investor Forum

GlobeNewswire November 5, 2015

iCAD Reports Third Quarter 2015 Financial Results

GlobeNewswire October 29, 2015

Researchers to Present Up to 5-Year Positive Clinical Data Supporting Use of Xoft System for Early-Stage Breast Cancer and Nonmelanoma Skin Cancer at ASTRO 2015

PR Newswire October 19, 2015